» Articles » PMID: 28070608

Xuebijing Injection Treatment Inhibits Vasopermeability and Reduces Fluid Requirements in a Canine Burn Model

Overview
Date 2017 Jan 11
PMID 28070608
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: High vasopermeability and excessive inflammation following severe burns may result in tissue edema, organ dysfunction and the loss of circulatory plasma volume, which can influence the doctor to do the prognosis to the patients. The study aims to examine whether Xuebijing injection (XBJ), an extracts of a traditional Chinese medicine used to treat sepsis in clinic, can reduces fluid requirements by inhibiting vasopermeability and tissue edema in a canine model after burn injury.

Methods: Twenty-four beagle dogs were subjected to 50% TBSA burns, and then were randomly allocated to the following three groups: lactated Ringer's resuscitation (LR) group (n = 8), immediate LR containing Xuebijing injection (LR/XBJ) group (n = 8), and operation control group (n = 8). Hemodynamic variables and net fluid accumulation were measured. Blood samples were collected for measurement of hematocrit and circulatory plasma volume (PV). At 24 h after burn injury, heart, lung, small intestine and kidney were harvested for evaluation of the activities of myeloperoxidase (MPO) and neutrophil elastase (NE), vasopermeability, tissue water content and the amount of neutrophil infiltration.

Results: XBJ treatment significantly reduced net fluid accumulation, and pulmonary vascular permeability index (PVPI), extravascular lung water index (ELWI), and water content of heart, small intestine, kidney and lung compared with LR group. Furthermore, XBJ infusion significantly reduced tissue activities of MPO and NE compared with LR group. The amount of neutrophil infiltration in LR/XBJ group was lower than that in LR group.

Conclusions: These results indicate that XBJ injection can reduce fluid requirements by inhibition of neutrophil protease-induced high vasopermeability and tissue edema.

Citing Articles

Xuebijing injection inhibited neutrophil extracellular traps to reverse lung injury in sepsis mice reducing Gasdermin D.

Shang T, Zhang Z, Wang X, Chang J, Zhou M, Lyu M Front Pharmacol. 2022; 13:1054176.

PMID: 36467039 PMC: 9710739. DOI: 10.3389/fphar.2022.1054176.


Early correction of coagulopathy reduces the 28day mortality in adult patients with largearea burns.

Xiao K, Zhao F, Liao X, Le A Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021; 46(8):851-857.

PMID: 34565729 PMC: 10929979. DOI: 10.11817/j.issn.1672-7347.2021.190817.


Effect of the infusion ration between frozen plasma and plasma substitutes on the prognosis of adult patients with major burn in shock stage.

Xiao K, Zhao F, Wan J, Le A Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021; 46(4):393-399.

PMID: 33967086 PMC: 10930309. DOI: 10.11817/j.issn.1672-7347.2021.190565.

References
1.
Zhang S, Sun C, Wen Y, Yin C . [Effect of treatment with Xuebijing injection on serum inflammatory mediators and Th1/2 of spleen in rats with sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006; 18(11):673-6. View

2.
Sun J, Xue Q, Guo L, Cui L, Wang J . Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits. Exp Lung Res. 2010; 36(4):211-8. DOI: 10.3109/01902140903312123. View

3.
COPE O, MOORE F . A STUDY OF CAPILLARY PERMEABILITY IN EXPERIMENTAL BURNS AND BURN SHOCK USING RADIOACTIVE DYES IN BLOOD AND LYMPH. J Clin Invest. 1944; 23(2):241-57. PMC: 435335. DOI: 10.1172/JCI101487. View

4.
Chai J, Cai J, Deng H, Zou X, Liu W, Hu Q . Role of neutrophil elastase in lung injury induced by burn-blast combined injury in rats. Burns. 2012; 39(4):745-53. DOI: 10.1016/j.burns.2012.08.005. View

5.
Ivy M, Possenti P, Kepros J, Atweh N, DAiuto M, Palmer J . Abdominal compartment syndrome in patients with burns. J Burn Care Rehabil. 1999; 20(5):351-3. DOI: 10.1097/00004630-199909000-00003. View